Your Resource for COVID-19 Related Thrombosis and Fibrinolysis Products

Posted: October 6, 2020

DIKI, DILI, NASH, NAFLD, ALD/AH

Your Resource for COVID-19 Related Thrombosis and Fibrinolysis Products

COAGULATION, FIBRINOLYSIS, ANTICOAGULATION, and IVIG Safety Testing/QC

Fibrinolytic Markers*: PAI-1, tPA, PAP

Bleeding Disorder Markers: vWF

DOAC Research* and Heparin Measurement Reagents

IQ HITAlert™*

Ceveron® s100*: Automated Thrombin Generation Testing (TGA), ADAMTS-13, and FXIII*

Inflammation Marker and Complement ELISAs*

Testing for Immunoglobulin (IVIG) preparations*: PKA, FXIa, TGA

*Research use only in the U.S. and Canada. Not for use in diagnostic procedures.

coagulation disorders

Announcing the First Quantitative SARS-COV-2 ELISAs for Detection of IgG Antibodies!

  • Ideal for COVID-19 research, epidemiological studies, and vaccine development
  • TECHNOZYM anti SARS-CoV-2 NP IgG test kit (cat. no.: 5600200)*
  • TECHNOZYM anti SARS-CoV-2 RBD IgG test kit (cat. no.: 5600100)*
  • Calibrators & Controls included; open-system, standard ELISAs that require no special readers and can be automated for higher throughput
  • IgA ELISAs also available – Unique- IgA is the major antibody class found in mucosal membranes and is a major factor of immunity for many other respiratory pathogens

*Research use only in the U.S. and Canada. Not for use in diagnostic procedures.

Contact us Today to Learn More.   diapharma.com 800.447.3846

ML-00-00687Rev01